![Melissa Manno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Manno
Responsable des Ressources Humaines chez KINIKSA PHARMACEUTICALS, LTD.
Postes actifs de Melissa Manno
Sociétés | Poste | Début | Fin |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Responsable des Ressources Humaines | 01/06/2018 | - |
Historique de carrière de Melissa Manno
Anciens postes connus de Melissa Manno
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2015 | 01/05/2017 |
SYNAGEVA BIOPHARMA CORP | Responsable des Ressources Humaines | 01/01/2014 | 01/06/2015 |
Formation de Melissa Manno
Keene State College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Synageva BioPharma Corp.
![]() Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Melissa Manno
- Expérience